LXRX ($1.91 PM) Lexicon Announces Positive Results In Phase 2 Trial Of LX4211 In Type 1 Diabetes Ref. http://m.nasdaq.com/article/lexicon-announces-positive-results-in-phase-2-trial-of-lx4211-in-type-1-diabetes-20140414-00093